Related Experiment Videos
Leptomeningeal metastases
1Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10019, USA. demopoua@mskcc.org
Current Neurology and Neuroscience Reports
|April 23, 2004
Summary
Leptomeningeal metastasis, or cancer spread to the brain and spinal cord linings, is a growing challenge in oncology. Current treatments are limited, highlighting the need for better diagnostic and therapeutic strategies.
Area of Science:
- Oncology
- Neurology
- Pathophysiology
Background:
- Leptomeningeal metastasis (LM) is the spread of cancer cells to the meninges and cerebrospinal fluid (CSF).
- It is an increasing complication in oncology due to longer patient survival and the failure of conventional therapies to cross the blood-brain barrier.
- LM presents with focal neurologic deficits and multifocal neurological signs.
Purpose of the Study:
- To review the clinical course of leptomeningeal metastasis.
- To discuss recent advancements in the pathophysiology, diagnosis, and treatment of LM.
Main Methods:
- Literature review of clinical course, pathophysiology, diagnosis, and treatment of LM.
- Analysis of current challenges and emerging strategies in managing LM.
Main Results:
- LM is a relentlessly progressive disease with limited treatment options and rare cures.
- Newer chemotherapies often fail to penetrate the blood-brain barrier, limiting efficacy.
- Diagnosis relies on clinical presentation of neurologic dysfunction.
Conclusions:
- Leptomeningeal metastasis represents a significant and growing challenge in cancer care.
- Further research into pathophysiology, diagnosis, and treatment is crucial for improving patient outcomes.
- Novel therapeutic approaches are needed to overcome the blood-brain barrier and effectively treat LM.